Arovella Therapeutics Limited (ASX:ALA)
Australia
· Delayed Price · Currency is AUD 0.0770
+0.0040 (5.48%)
Mar 10, 2026, 11:21 AM AEST
Arovella Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 19.37 | 20.88 | 12.71 | 5.18 | 6.07 | 6.72 | Upgrade
|
| Cash & Short-Term Investments | 19.37 | 20.88 | 12.71 | 5.18 | 6.07 | 6.72 | Upgrade
|
| Cash Growth | 64.81% | 64.20% | 145.67% | -14.75% | -9.62% | 587.20% | Upgrade
|
| Accounts Receivable | 0.13 | - | - | 0.01 | 0.04 | 0.01 | Upgrade
|
| Other Receivables | - | 0.11 | 0.18 | 0 | 0 | 0.52 | Upgrade
|
| Receivables | 0.13 | 0.11 | 0.18 | 0.01 | 0.04 | 0.53 | Upgrade
|
| Prepaid Expenses | - | 0.11 | 0.21 | 0.03 | 0.06 | 0.09 | Upgrade
|
| Other Current Assets | 0.34 | 0.07 | 0.05 | 0.2 | 0.42 | - | Upgrade
|
| Total Current Assets | 19.84 | 21.17 | 13.15 | 5.42 | 6.59 | 7.34 | Upgrade
|
| Property, Plant & Equipment | 0.41 | 0.43 | 0.13 | 0.05 | 0.37 | 0.43 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.13 | 0.13 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 2.12 | 2.78 | Upgrade
|
| Total Assets | 20.25 | 21.6 | 13.28 | 5.47 | 9.21 | 10.69 | Upgrade
|
| Accounts Payable | 0.76 | 0.94 | 0.98 | 0.77 | 0.75 | 0.23 | Upgrade
|
| Accrued Expenses | 0.14 | 0.13 | 0.08 | 0.3 | 0.28 | 0.2 | Upgrade
|
| Current Portion of Leases | - | - | - | - | 0.07 | 0.08 | Upgrade
|
| Current Unearned Revenue | - | - | 0.14 | 0.15 | 0.34 | 0.2 | Upgrade
|
| Other Current Liabilities | 0.39 | 0.42 | 0.84 | 0.45 | 0.06 | 1 | Upgrade
|
| Total Current Liabilities | 1.29 | 1.49 | 2.04 | 1.68 | 1.51 | 1.69 | Upgrade
|
| Long-Term Leases | - | - | - | - | 0.08 | 0 | Upgrade
|
| Other Long-Term Liabilities | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Liabilities | 1.33 | 1.52 | 2.06 | 1.69 | 1.6 | 1.71 | Upgrade
|
| Common Stock | 120.9 | 120.13 | 104.3 | 88.87 | 83.54 | 77 | Upgrade
|
| Retained Earnings | -104.37 | -102.84 | -95.51 | -87.06 | -77.02 | -68.47 | Upgrade
|
| Comprehensive Income & Other | 2.38 | 2.79 | 2.44 | 1.96 | 1.11 | 0.45 | Upgrade
|
| Total Common Equity | 18.92 | 20.08 | 11.23 | 3.78 | 7.62 | 8.98 | Upgrade
|
| Shareholders' Equity | 18.92 | 20.08 | 11.23 | 3.78 | 7.62 | 8.98 | Upgrade
|
| Total Liabilities & Equity | 20.25 | 21.6 | 13.28 | 5.47 | 9.21 | 10.69 | Upgrade
|
| Total Debt | - | - | - | - | 0.14 | 0.08 | Upgrade
|
| Net Cash (Debt) | 19.37 | 20.88 | 12.71 | 5.18 | 5.93 | 6.64 | Upgrade
|
| Net Cash Growth | 64.81% | 64.20% | 145.67% | -12.67% | -10.72% | 644.16% | Upgrade
|
| Net Cash Per Share | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 1,196 | 1,189 | 1,051 | 849.91 | 669.84 | 480.82 | Upgrade
|
| Total Common Shares Outstanding | 1,196 | 1,189 | 1,051 | 849.91 | 669.84 | 480.82 | Upgrade
|
| Working Capital | 18.55 | 19.68 | 11.11 | 3.74 | 5.08 | 5.65 | Upgrade
|
| Book Value Per Share | 0.02 | 0.02 | 0.01 | 0.00 | 0.01 | 0.02 | Upgrade
|
| Tangible Book Value | 18.92 | 20.08 | 11.23 | 3.78 | 7.48 | 8.85 | Upgrade
|
| Tangible Book Value Per Share | 0.02 | 0.02 | 0.01 | 0.00 | 0.01 | 0.02 | Upgrade
|
| Machinery | - | 0.71 | 0.34 | 0.25 | 1.07 | 1.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.